FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

3871011000001105: Zeffix 100mg tablets (GlaxoSmithKline) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17956701000001116 Zeffix 100mg tablets (GlaxoSmithKline) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
58158901000001115 Zeffix 100mg tablets (GlaxoSmithKline UK Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Zeffix 100mg tablets (GlaxoSmithKline) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Zeffix 100mg tablets (GlaxoSmithKline) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Zeffix 100mg tablets (GlaxoSmithKline) Is a Product containing precisely lamivudine 100 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Zeffix 100mg tablets (GlaxoSmithKline) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Zeffix 100mg tablets (GlaxoSmithKline) Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Zeffix 100mg tablets (GlaxoSmithKline) Has active ingredient Lamivudine false Inferred relationship Existential restriction modifier
Zeffix 100mg tablets (GlaxoSmithKline) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Zeffix 100mg tablets (GlaxoSmithKline) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Zeffix 100mg tablets (GlaxoSmithKline) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Zeffix 100mg tablets (GlaxoSmithKline) Is a Zeffix true Inferred relationship Existential restriction modifier
Zeffix 100mg tablets (GlaxoSmithKline) Has specific active ingredient Lamivudine true Inferred relationship Existential restriction modifier
Zeffix 100mg tablets (GlaxoSmithKline) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Zeffix 100mg tablets (GlaxoSmithKline) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Zeffix 100mg tablets (GlaxoSmithKline) 28 tablet 2 x 14 tablets Is pack of False Zeffix 100mg tablets (GlaxoSmithKline) Inferred relationship Existential restriction modifier
Zeffix 100mg tablets (GlaxoSmithKline) 28 tablet 2 x 14 tablets Has AMP True Zeffix 100mg tablets (GlaxoSmithKline) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start